Cited by 400Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain

Open access

Sasaki, Atsuo, Yasukawa, Hideo, Suzuki, Asuka, Kamizono, Shintaro, Syoda, Takanori, Kinjyo, Ichiko, Sasaki, Mika, Johnston, James A., Yoshimura, Akihiko·1999·Genes to Cells

DOI 10.1046/j.1365-2443.1999.00263.x

Open this paper in CoChat — free account Open PDF

Abstract

Background: The Janus family of protein tyrosine kinases (JAKs) regulate cellular processes involved in cell growth, differentiation and transformation through their association with cytokine receptors. We have recently identified the JAK‐binding protein, JAB that inhibits various cytokine‐dependent JAK signalling pathways. JAB inhibits JAK2 tyrosine kinase activity by binding to the kinase domain (JH1 domain) through the N‐terminal kinase inhibitory region (KIR) and the SH2 domain. The SH2 domain of JAB has been shown to bind to the phosphorylated Y1007 in the activation loop of JH1. We also identified another JAK‐binding protein, CIS3 (cytokine‐inducible SH2‐protein 3, or SOCS3) that inhibits signalling of various cytokines. However, the mechanism of JAK signal inhibition by CIS3 has not been clarified. Results: We showed that endogenous CIS3 bound to JAK2 in intact cells. The CIS3‐SH2 domain bound to the phosphorylated Y1007 of JH1, and inhibited tyrosine kinase activity through the N‐terminal KIR. Therefore, CIS3 and JAB inhibit JAK2 tyrosine kinase activity by an essentially similar mechanism. However, we found that the affinity of the SH2 domain of CIS3 to Y1007 was weaker than that of JAB. In contrast, the KIR of CIS3 showed stronger potential for both binding to JH1 and inhibition of JAK kinase activity than that of JAB. Consistent with this notion, chimeras containing CIS3‐KIR and JAB‐SH2 domain inhibited JAK2 kinase activity more efficiently than the wild‐type CIS3 or JAB. Conclusion: CIS3 inhibits JAK2 kinase activity by binding to the activation loop through the SH2 domain, and KIR is necessary for kinase inhibition. Although the inhibitory mechanism by CIS3 is similar to that by JAB, the contributions of the SH2 domain and KIR for binding are different between JAB and CIS3. Our study defined the inhibitory mechanism of CIS3 and provides a useful information for creating a novel tyrosine kinase inhibitor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2443.1999.00263.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Self-citation
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Cytokine receptor signalling
Ihle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,201
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Identification of SOCS-3 as a Potential Mediator of Central Leptin Resistance
Bjørbæk, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E., & Flier, J. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80062-3 · Cited by 1,014
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07281.x · Cited by 751
Self-citation
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., Jr., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 734
Twenty proteins containing a C-terminal SOCS box form five structural classes
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D., & Nicola, N. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.114 · Cited by 728

Show all 28 references

Sorted by citations

Items 101–200 of 400

Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways
Puhr, M., Santer, F. R., Neuwirt, H., Susani, M., Nemeth, J. A., Hobisch, A., Kenner, L., & Čulig, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0806 · Cited by 84
Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling ( SOCS ) proteins
Linossi, E. M., & Nicholson, S. E. (2015) · Immunological Reviews · doi:10.1111/imr.12305 · Cited by 86
Suppressor of Cytokine Signaling (SOCS)-3 Protein Interacts with the Insulin-like Growth Factor-I Receptor
Dey, B. R., Furlanetto, R. W., & NISSLEY, P. S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3762 · Cited by 83
A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production
Matsumoto, A., Seki, Y.-I., Watanabe, R., Hayashi, K., Johnston, J. A., Harada, Y., Abe, R., Yoshimura, A., & Kubo, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020939 · Cited by 82
Self-citation
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
Menter, T., Juškevičius, D., Alikian, M., Steiger, J., Dirnhofer, S., Tzankov, A., & Naresh, K. N. (2017) · British Journal of Haematology · doi:10.1111/bjh.14633 · Cited by 82
An activity-dependent determinant of synapse elimination in the mammalian brain
Yasuda, M., Nagappan-Chettiar, S., Johnson‐Venkatesh, E., & Umemori, H. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.006 · Cited by 83
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
van de Geijn, G. M., Gits, J., Aarts, L. H. J., Heijmans‐Antonissen, C., & Touw, I. P. (2004) · Blood · doi:10.1182/blood-2003-08-2913 · Cited by 78
Role of Tyrosine 441 of Interferon-γ Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation
Qing, Y., Costa‐Pereira, A. P., Watling, D., & Stark, G. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409863200 · Cited by 78
Regulation of CD4 + T‐cell polarization by suppressor of cytokine signalling proteins
Knosp, C. A., & Johnston, J. A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03520.x · Cited by 80
Self-citation
Treatment of Mice with the Suppressor of Cytokine Signaling-1 Mimetic Peptide, Tyrosine Kinase Inhibitor Peptide, Prevents Development of the Acute Form of Experimental Allergic Encephalomyelitis and Induces Stable Remission in the Chronic Relapsing/Remitting Form
Mujtaba, M. G., Flowers, L. O., Patel, C. B., Patel, R. A., Haider, M. I., & Johnson, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5077 · Cited by 77
Regulation of Janus kinases by SOCS proteins
Kershaw, N. J., Murphy, J. M., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130077 · Cited by 75
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1)
Giordanetto, F., & Kroemer, R. T. (2003) · Protein Engineering Design and Selection · doi:10.1093/proeng/gzg015 · Cited by 76
Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling
Skjesol, A., Liebe, T., Iliev, D. B., Thomassen, E. I. S., Greiner-Tollersrud, L., Sobhkhez, M., Joensen, L. L., Secombes, C. J., & Jørgensen, J. B. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.02.009 · Cited by 75
Ankyrin Repeat and SOCS Box 3 (ASB3) Mediates Ubiquitination and Degradation of Tumor Necrosis Factor Receptor II
Chung, A. S., Guan, Y. A., Yuan, Z., Albina, J. E., & Chin, Y. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4716-4726.2005 · Cited by 75
Methylation ofSOCS3is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity
Ali, O., Cerjak, D., Kent, J. W., James, R. G., Blangero, J., Carless, M. A., & Zhang, Y. (2016) · Epigenetics · doi:10.1080/15592294.2016.1216284 · Cited by 75
The Inhibition of Interleukin-6-dependent STAT Activation by Mitogen-activated Protein Kinases Depends on Tyrosine 759 in the Cytoplasmic Tail of Glycoprotein 130
Terstegen, L., Gatsios, P., Bode, J. G., Schaper, F., Heinrich, P. C., & Graeve, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m904148199 · Cited by 73
Macrophage-Stimulating Protein, the Ligand for the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase, Inhibits IL-12 Production by Primary Peritoneal Macrophages Stimulated with IFN-γ and Lipopolysaccharide
Morrison, A. C., Wilson, C. B., Ray, M., & Correll, P. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1825 · Cited by 73
SOCS5 Is Expressed in Primary B and T Lymphoid Cells but Is Dispensable for Lymphocyte Production and Function
Brender, C., Columbus, R., Metcalf, D., Handman, E., Starr, R., Huntington, N. D., Tarlinton, D. M., Ødum, N., Nicholson, S. E., Nicola, N. A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6094-6103.2004 · Cited by 73
Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus
Moshapa, F. T., Riches‐Suman, K., & Palmer, T. M. (2019) · Cardiology Research and Practice · doi:10.1155/2019/9846312 · Cited by 76
The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo
Boyle, K., Egan, P. J., Rakar, S., Willson, T. A., Wicks, I. P., Metcalf, D., Hilton, D. J., Nicola, N. A., Alexander, W. S., Roberts, A. W., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079178 · Cited by 74
A Mutant Form of JAB/SOCS1 Augments the Cytokine-induced JAK/STAT Pathway by Accelerating Degradation of Wild-type JAB/CIS Family Proteins through the SOCS-box
Hanada, T., Yoshida, T., Kinjyo, I., Minoguchi, S., Yasukawa, H., Kato, S., Mimata, H., Nomura, Y., Seki, Y., Kubo, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106139200 · Cited by 72
Self-citation
FXR ligands protect against hepatocellular inflammation via SOCS3 induction
Xu, Z., Huang, G., Gong, W., Zhou, P., Zhao, Y., Zhang, Y., Zeng, Y., Gao, M., Pan, Z., & He, F. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.015 · Cited by 71
Activation of the transcription factor NF-κB by the erythropoietin receptor
Bittorf, T., Büchse, T., Sasse, T., Jaster, R., & Brock, J. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00189-9 · Cited by 70
Regulation of the inflammatory response of vascular endothelial cells by EPAC1
Parnell, E., Smith, B. O., Palmer, T. M., Terrin, A., Zaccolo, M., & Yarwood, S. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01808.x · Cited by 71
LIF signal in mouse embryonic stem cells
Ohtsuka, S., Nakai, Y., & Niwa, H. (2015) · JAK-STAT · doi:10.1080/21623996.2015.1086520 · Cited by 74
Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins
McCormick, S. M., & Heller, N. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00549 · Cited by 69
JAK2V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
Oh, S. T., & Gotlib, J. R. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.28 · Cited by 67
Understanding the role of SOCS signaling in neurodegenerative diseases: Current and emerging concepts
Cianciulli, A., Calvello, R., Porro, C., Trotta, T., & Panaro, M. A. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.07.005 · Cited by 59
Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation
Boyle, K., Zhang, J., Nicholson, S. E., Trounson, E., Babon, J. J., McManus, E. J., Nicola, N. A., & Robb, L. G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.002 · Cited by 69
Sox6 enhances erythroid differentiation in human erythroid progenitors
Cantù, C., Ierardi, R., Alborelli, I., Fugazza, C., Cassinelli, L., Piconese, S., Bosè, F., Ottolenghi, S., Ferrari, G., & Ronchi, A. E. (2011) · Blood · doi:10.1182/blood-2010-04-282350 · Cited by 65
Roles of Stat3 and ERK in G‐CSF Signaling
Kamezaki, K., Shimoda, K., Numata, A., Haro, T., Kakumitsu, H., Yoshie, M., Yamamoto, M., Takeda, K., Matsuda, T., Akira, S., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0173a · Cited by 66
Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player
Uren, R. T., & Turnley, A. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00039 · Cited by 70
Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1
Hirata, Y., Brems, H., Suzuki, M., Kanamori, M., Okada, M., Morita, R., Llano‐Rivas, I., Ose, T., Messiaen, L. M., Legius, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703710 · Cited by 63
Self-citation
IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins
Zimmerer, J. M., Lesinski, G. B., Kondadasula, S. V., Karpa, V. I., Lehman, A., Ray‐Chaudhury, A., Becknell, B., & Carson, W. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4832 · Cited by 62
Turning off signal transducer and activator of transcription (STAT): The negative regulation of STAT signaling
Chen, W., Daines, M., & Hershey, G. K. K. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.042 · Cited by 66
Cell-Type-Specific Type I Interferon Antagonism Influences Organ Tropism of Murine Coronavirus
Zhao, L., Rose, K. M., Elliott, R., van Rooijen, N., & Weiss, S. R. (2011) · Journal of Virology · doi:10.1128/jvi.05075-11 · Cited by 63
IL-4 and IL-13 Induce SOCS-1 Gene Expression in A549 Cells by Three Functional STAT6-Binding Motifs Located Upstream of the Transcription Initiation Site
Hebenstreit, D., Luft, P., Schmiedlechner, A., Regl, G., Frischauf, A., Aberger, F., Duschl, A., & Horejs‐Hoeck, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5901 · Cited by 63
New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries
Doti, N., Scognamiglio, P. L., Madonna, S., Scarponi, C., Ruvo, M., Perretta, G., Albanesi, C., & Marasco, D. (2011) · Biochemical Journal · doi:10.1042/bj20111647 · Cited by 63
Growth Hormone Receptor Regulation in Cancer and Chronic Diseases
Strous, G. J., Almeida, A. D. S., Putters, J., Schantl, J., Sędek, M., Slotman, J. A., Nespital, T., Hassink, G. C., & Mol, J. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597573 · Cited by 61
Structural Basis for Phosphotyrosine Recognition by Suppressor of Cytokine Signaling-3
Bergamin, E., Wu, J., & Hubbard, S. R. (2006) · Structure · doi:10.1016/j.str.2006.06.011 · Cited by 60
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., & Du, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336102 · Cited by 68
The Role of Suppressors of Cytokine Signalling in Human Neoplasms
Sasi, W., Sharma, A. K., & Mokbel, K. (2014) · Molecular Biology International · doi:10.1155/2014/630797 · Cited by 60
Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by GrowthHormone and Epidermal Growth Factor
Mazurkiewicz-Muñoz, A. M., Argetsinger, L. S., Kouadio, J.-L. K., Stensballe, A., Jensen, O. N., Cline, J. M., & Carter‐Su, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01591-05 · Cited by 58
Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome
McCormick, S. M., Gowda, N. M., Fang, J., & Heller, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746164 · Cited by 56
SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity
Bidgood, G. M., Keating, N., Doggett, K., & Nicholson, S. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1419951 · Cited by 61
SOCS proteins in infectious diseases of mammals
Delgado-Ortega, M., Marc, D., Dupont, J., Trapp, S., Berri, M., & Meurens, F. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.11.008 · Cited by 61
Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling
Ben‐Zvi, T., Yayon, A., Gertler, A., & Ornan, E. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.02740 · Cited by 56
Exercise-Induced Activation of STAT3 Signaling Is Increased with Age
Caldow, M. K., Carey, K. A., Ward, A. C., Farnfield, M. M., & Cameron‐Smith, D. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0643 · Cited by 57
Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells
Wiejak, J., Dunlop, J., Mackay, S. P., & Yarwood, S. J. (2013) · Biochemical Journal · doi:10.1042/bj20130481 · Cited by 55
Suppressor of Cytokine Signaling (SOCS) 5 Utilises Distinct Domains for Regulation of JAK1 and Interaction with the Adaptor Protein Shc-1
Linossi, E. M., Chandrashekaran, I. R., Kolesnik, T. B., Murphy, J. M., Webb, A. I., Willson, T. A., Kedzierski, Ł., Bullock, A. N., Babon, J. J., Norton, R. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070536 · Cited by 54
SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells
Dhar, K., Rakesh, K., Pankajakshan, D., & Agrawal, D. K. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00570.2012 · Cited by 58
SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity
Liu, D., Sheng, C., Gao, S., Yao, C., Li, J., Jiang, W., Chen, H., Wu, J., Pan, C., Chen, S., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00090-15 · Cited by 53
Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion
Neuwirt, H., Puhr, M., Cavarretta, I. T. R., Mitterberger, M., Hobisch, A., & Čulig, Z. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0172 · Cited by 52
Transcriptome Functional Analysis of Mammary Gland of Cows in Heat Stress and Thermoneutral Condition
Yue, S., Wang, Z., Wang, L., Peng, Q., & Xue, B. (2020) · Animals · doi:10.3390/ani10061015 · Cited by 53
Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway
Uotani, S., Abe, T., & Yamaguchi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.015 · Cited by 56
JAK's SOCS: A Mechanism of Inhibition
Yoshimura, A., & Yasukawa, H. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.010 · Cited by 54
Self-citation
SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling
Haan, S., Wüller, S., Kaczor, J., Rolvering, C., Nocker, T., Behrmann, I., & Haan, C. (2009) · Oncogene · doi:10.1038/onc.2009.155 · Cited by 51
Advances in understanding the pathogenesis of primary familial and congenital polycythaemia
Huang, L. J.-S., Shen, Y.-M. P., & Bulut, G. B. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08069.x · Cited by 52
SOCS3
White, C. A., & Nicola, N. A. (2013) · JAK-STAT · doi:10.4161/jkst.25045 · Cited by 53
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.
Ortmann, R., Cheng, T. P., Visconti, R., Frucht, D. M., & O’Shea, J. J. (2000) · Arthritis Research · doi:10.1186/ar66 · Cited by 50
Insulin decreases hepatic acute phase protein levels in severely burned children
Wu, X., Thomas, S. J., Herndon, D. N., Sanford, A. P., & Wolf, S. E. (2004) · Surgery · doi:10.1016/j.surg.2003.08.018 · Cited by 50
Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models
Barrios-Correa, A. A., Estrada, J. A., & Contreras, I. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1185-0 · Cited by 54
DrosophilaSOCS36E negatively regulates JAK/STAT pathway signaling via two separable mechanisms
Stec, W. J., Vidal, O. M., & Zeidler, M. P. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-05-0275 · Cited by 48
Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain
Babon, J. J., Yao, S., DeSouza, D. P., Harrison, C. F., Fabri, L., Liepinsh, E., Scrofani, S. D. B., Baca, M., & Norton, R. S. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05010.x · Cited by 48
SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome
Vuong, B. Q., Arenzana, T. L., Showalter, B. M., Losman, J. A., Chen, X. P., Mostecki, J. W., Banks, A. S., Limnander, A., Fernandez, N., & Rothman, P. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9092-9101.2004 · Cited by 47
Dectin-1 Stimulation Induces Suppressor of Cytokine Signaling 1, Thereby Modulating TLR Signaling and T Cell Responses
Eberle, M.-E., & Dalpke, A. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103068 · Cited by 46
Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity
Numata, K., Kubo, M., Watanabe, H. A., Takagi, K., Mizuta, H., Okada, S., Kunkel, S. L., Ito, T., & Matsukawa, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3777 · Cited by 46
IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells
O’Connell, D., Bouazza, B., Kokalari, B., Amrani, Y., Khatib, A., Ganther, J. D., & Tliba, O. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00099.2015 · Cited by 46
A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes
Du, Z., & Uversky, V. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102010 · Cited by 47
Natural killer cells and anti-tumor immunity
Nicholson, S. E., Keating, N., & Belz, G. T. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.002 · Cited by 46
Aflatoxin B1 Induces Immunotoxicity through the DNA Methyltransferase-Mediated JAK2/STAT3 Pathway in 3D4/21 Cells
Zhou, X., Gan, F., Hou, L., Liu, Z., Su, J., Lin, Z., Le, G., & Huang, K. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07309 · Cited by 48
Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer
Manna, S. L., Lee, E.-M., Ouzounova, M., Natale, C. D., Novellino, E., Merlino, A., Körkaya, H., & Marasco, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31594 · Cited by 44
Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit
Pircher, T. J., Geiger, J. N., Zhang, D., Miller, C. P., Gaines, P. C. W., & Wojchowski, D. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007473200 · Cited by 45
Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells
Shouda, T., Hiraoka, K., Komiya, S., Hamada, T., Zenmyo, M., Iwasaki, H., Isayama, T., Fukushima, N., Nagata, K., & Yoshimura, A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.042 · Cited by 44
Self-citation
Expression of SOCS1-7 and CIS mRNA in porcine tissues
Delgado-Ortega, M., Melo, S., & Meurens, F. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.08.002 · Cited by 45
Negative regulation of cytokine signaling and inflammatory diseases
Inagaki-Ohara, K. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00070-5 · Cited by 41
Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases
Hanada, T., Kinjyo, I., Inagaki-Ohara, K., & Yoshimura, A. (2003) · Springer eBooks · doi:10.1007/s10254-003-0015-z · Cited by 43
Self-citation
Enterovirus 71 Inhibits Cellular Type I Interferon Signaling by Downregulating JAK1 Protein Expression
Liu, Y., Zhang, Z., Zhao, X., Yu, R., Zhang, X., Wu, S., Liu, J., Chi, X., Song, X., Fu, L., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0127 · Cited by 43
Reconstruction of an active SOCS3-based E3 ubiquitin ligase complexin vitro: identification of the active components and JAK2 and gp130 as substrates
Kershaw, N. J., Laktyushin, A., Nicola, N. A., & Babon, J. J. (2014) · Growth Factors · doi:10.3109/08977194.2013.877005 · Cited by 46
Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase
Kung, W.-W., Ramachandran, S., Makukhin, N., Bruno, E., & Ciulli, A. (2019) · Nature Communications · doi:10.1038/s41467-019-10190-4 · Cited by 42
Oncostatin M Receptor-mediated Signal Transduction Is Negatively Regulated by SOCS3 through a Receptor Tyrosine-independent Mechanism
Stroß, C., Radtke, S., Clahsen, T., Gerlach, C., Volkmer, R., Schaper, F., Heinrich, P. C., & Hermanns, H. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511212200 · Cited by 41
Suppressor of Cytokine Signaling 3 Inhibits LPS-induced IL-6 Expression in Osteoblasts by Suppressing CCAAT/Enhancer-binding Protein β Activity
Yan, C., Cao, J., Wu, M., Zhang, W., Jiang, T., Yoshimura, A., & Gao, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132084 · Cited by 41
Self-citation
Activating mutations of the gp130/JAK/STAT pathway in human diseases
Lokau, J., & Garbers, C. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.007 · Cited by 41
SOCS3 regulates graft-versus-host disease
Hill, G. R., Kuns, R. D., Raffelt, N. C., Don, A. L. J., Olver, S. D., Markey, K. A., Wilson, Y. A., Tocker, J. E., Alexander, W. S., Clouston, A. D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259598 · Cited by 40
Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation
Sommer, U., Schmid, C., Sobota, R. M., Lehmann, U., Stevenson, N. J., Johnston, J. A., Schaper, F., Heinrich, P. C., & Haan, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506008200 · Cited by 42
Self-citation
Post-Receptor Inhibitors of the GHR-JAK2-STAT Pathway in the Growth Hormone Signal Transduction
Wójcik, M., Krawczyńska, A., Antushevich, H., & Herman, A. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071843 · Cited by 39
SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro
Zhang, S., Guo, D., Jiang, L., Zhang, Q., Qiu, X., & Wang, E. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-150 · Cited by 38
Modulation of Host Cell Gene Expression through Activation of STAT Transcription Factors by Pasteurella multocida Toxin
Orth, J. H. C., Aktories, K., & Kubatzky, K. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609018200 · Cited by 38
Hepatocyte growth control by SOCS1 and SOCS3
Khan, M. G. M., Ghosh, A., Variya, B. C., Santharam, M. A., Kandhi, R., Ramanathan, S., & Ilangumaran, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154733 · Cited by 38
SOCS1: Regulator of T Cells in Autoimmunity and Cancer
Ilangumaran, S., Bobbala, D., & Ramanathan, S. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_63 · Cited by 37
SOCS: negative regulators of cytokine signaling for immune tolerance
Yoshimura, A., Ito, M., Mise‐Omata, S., & Ando, M. (2021) · International Immunology · doi:10.1093/intimm/dxab055 · Cited by 38
Self-citation
Methylation and microRNA-mediated epigenetic regulation of SOCS3
Boosani, C. S., & Agrawal, D. K. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3860-3 · Cited by 37
Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression
Williams, J. J. L., Munro, K. M., & Palmer, T. M. (2014) · Cells · doi:10.3390/cells3020546 · Cited by 38
Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability
Williams, J. J. L., Alotaiq, N., Mullen, W., Burchmore, R., Liu, L., Baillie, G. S., Schaper, F., Pilch, P. F., & Palmer, T. M. (2018) · Nature Communications · doi:10.1038/s41467-017-02585-y · Cited by 35
Four CISH paralogues are present in rainbow trout Oncorhynchus mykiss: Differential expression and modulation during immune responses and development
Maehr, T., Vecino, J. L. G., Wadsworth, S., Wang, T., & Secombes, C. J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.021 · Cited by 36
Dynamics of rumen gene expression, microbiome colonization, and their interplay in goats
Pan, X., Li, Z., Li, B., Zhao, C., Wang, Y., Chen, Y., & Jiang, Y. (2021) · BMC Genomics · doi:10.1186/s12864-021-07595-1 · Cited by 37
Growth Hormone Down-Regulation of Interleukin-1?? and Interleukin-6 Induced Acute Phase Protein Gene Expression is Associated with Increased Gene Expression of Suppressor of Cytokine Signal-3
Wu, X., Herndon, D. N., & Wolf, S. E. (2003) · Shock · doi:10.1097/00024382-200304000-00004 · Cited by 36
Pharmacology of inhibitors of Janus kinases – Part 1: Pharmacokinetics
Eichner, A., & Wohlrab, J. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14921 · Cited by 35
Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling
van de Geijn, G. M., Gits, J., & Touw, I. P. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104041 · Cited by 35
Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease
Gu, Q., Kong, Y., Yu, Z., Li, B., & Xiao, Y. (2011) · Biochimie · doi:10.1016/j.biochi.2011.02.009 · Cited by 36

Authors: Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A.
Affiliations: Kurume University (JP)
Corresponding author: Yoshimura, Akihiko
ORCID: Sasaki, Atsuo
Yasukawa, Hideo
Suzuki, Asuka
Kinjyo, Ichiko
Sasaki, Mika
Yoshimura, Akihiko
Venue: Genes to Cells
Publisher: Wiley
Published: 1999-06
Volume: 4
Issue: 6
Pages: 339-351
ISSN: 1356-9597 (ISSN-L)
1365-2443
DOI: 10.1046/j.1365-2443.1999.00263.x
OpenAlex: W2008295144
Cited by: 398
References: 28
Citations by year: 2026: 5 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 15 · 2017: 15 · 2016: 8 · 2015: 17 · 2014: 19 · 2013: 18 · 2012: 29
FWCI: 5.24
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 938 d)
Locations: Genes to Cells (publishedVersion)
PubMed (publishedVersion)
Funders: Naito Foundation
Sumitomo Foundation
Kanae Foundation for the Promotion of Medical Science
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: SOCS3, JAK2, SH2 domain, jab, cytokine signaling, protein tyrosine kinase inhibitors, fusion protein
MeSH terms: Suppressor of Cytokine Signaling 3 Protein, Amino Acid Sequence, Enzyme Activation, Humans, Molecular Sequence Data, Phosphorylation, Protein Binding, Protein-Tyrosine Kinases, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Signal Transduction, src Homology Domains, Suppressor of Cytokine Signaling Proteins, Janus Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks